#Pfizer39s #Covid19 #vaccine #safe #December
[ad_1]
Dr. Scott Gottlieb says the application for Pfizer’s Covid vaccine was sent today. It will take the FDA two to four weeks to review the application and the vaccine could be given to the first patients sometime in December. He joins ‘Closing Bell’ to discuss. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
Texas is preparing to start administering the first Covid-19 immunization shots in less than three weeks — as soon as the U.S. Food and Drug Administration grants emergency approval to distribute Pfizer’s or Moderna’s vaccine.
It’s a gargantuan task for the second-most populated state in the nation. The coronavirus has swept across the Lone Star State after it reopened its economy in May. It has confirmed more Covid-19 cases than any other state at roughly 1.2 million and has seen the second-most deaths behind New York, losing more than 21,000 Texans to the virus so far, according to data compiled by Johns Hopkins University. Hospitals in border cities like El Paso have been overwhelmed with cases, even bringing in extra morgue trucks to store the dead.
The state rolled out its vaccine allocation plan Monday, outlining who will get it first. Top priority is going to hospital employees and nursing home staff, EMTs, home health-care workers and the state’s most vulnerable residents. Gov. Greg Abbott said the state is prepared to distribute the vaccine as early as Dec. 12.
“We have known months in advance that the vials of the vaccine are already in place,” Abbott told CNBC. “And those vials are ready to be sent to us the day after the emergency use authorization is provided.”
Every state across the U.S. has submitted plans to the U.S. Centers for Disease Control and Prevention covering how they will store and distribute a coronavirus vaccine.
However, the vaccine won’t be shipped until it wins approval from the FDA for emergency use. Pfizer submitted its application for emergency clearance on Friday, and the FDA is expected to review it when the agency’s Vaccines and Related Biological Products Advisory Committee next meets on Dec. 10. Moderna is expected to submit its application any day. So both vaccines could potentially get reviewed at the same time.
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
[ad_2]
